Aceto Co. (NASDAQ:ACET) SVP Steven Rogers sold 3,769 shares of the firm’s stock in a transaction on Friday, September 7th. The stock was sold at an average price of $3.33, for a total transaction of $12,550.77. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Steven Rogers also recently made the following trade(s):
- On Thursday, July 5th, Steven Rogers sold 1,230 shares of Aceto stock. The stock was sold at an average price of $3.69, for a total transaction of $4,538.70.
Shares of NASDAQ:ACET traded down $0.17 during midday trading on Friday, hitting $3.23. The stock had a trading volume of 201,264 shares, compared to its average volume of 162,544. The company has a market cap of $104.68 million, a price-to-earnings ratio of 2.71 and a beta of 1.63. The company has a quick ratio of 0.80, a current ratio of 1.12 and a debt-to-equity ratio of 0.63. Aceto Co. has a 1 year low of $2.22 and a 1 year high of $11.98.
Separately, ValuEngine raised shares of Aceto from a “sell” rating to a “hold” rating in a report on Thursday, August 2nd. Four investment analysts have rated the stock with a sell rating and one has issued a hold rating to the company. The company presently has an average rating of “Sell” and a consensus price target of $2.00.
Several large investors have recently modified their holdings of ACET. Spark Investment Management LLC purchased a new stake in shares of Aceto in the second quarter valued at about $116,000. Jane Street Group LLC purchased a new stake in shares of Aceto in the second quarter valued at about $147,000. Laurion Capital Management LP boosted its holdings in shares of Aceto by 226.0% in the second quarter. Laurion Capital Management LP now owns 44,613 shares of the company’s stock valued at $150,000 after acquiring an additional 30,929 shares in the last quarter. Hartford Investment Management Co. purchased a new stake in shares of Aceto in the second quarter valued at about $171,000. Finally, LMR Partners LLP purchased a new stake in shares of Aceto in the second quarter valued at about $268,000. 59.76% of the stock is currently owned by institutional investors and hedge funds.
Aceto Company Profile
Aceto Corporation, together with its subsidiaries, sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The company operates in three segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals.
Featured Story: Calculate Your Return on Investment (ROI)
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.